跳至主要内容
临床试验/NCT02178839
NCT02178839Unknown不适用

The Effect of Oral β- Glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver Echogenicity and Enzymes in Non Alcoholic Fatty Liver Disease Treating With Hypocaloric Diet and Vitamin E

Urmia University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
48
试验地点
1
主要终点
Liver Echogenicity

研究概览

简要总结

The Objective of This Study is Evaluating the Effect of oral β- glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver echogenicity and Enzymes in Non Alcoholic Fatty Liver Patients Treating with Hypocaloric Diet and Vitamin E.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Non Alcoholic Fatty Liver Disease From Both Sex
  • Age 18-55 years
  • BMI more than 25 Kg/m2

排除标准

  • Alcohol Consumption
  • Pregnancy or lactation or menopause
  • Being a professional athlete
  • A history of cancer
  • Risk of high blood pressure (in the case of drug use)
  • Heart disease - cardiovascular, pulmonary, renal and diabetes
  • Liver transplantation and other chronic or acute Liver diseases such as hepatitis B, C and liver infections
  • The History of inherited disorders affecting the liver
  • A history of autoimmune disease
  • History of food allergies
  • Taking certain medications such as blood pressure control, statins, insulin sensitivity enhancers and hepatotoxic drugs

结局指标

主要结局

Liver Echogenicity

时间窗: 8 weeks

Liver Echogenicity Describes by Grade,

Liver Enzymes

时间窗: 8 weeks

Enzymes ALP (Alkanin Phosphatase), ALT (Alanin Amino Transferase) and AST (Aspartat Amino Transferase)

次要结局

  • Anthropometric Measurement WHtR(4 weeks, 8 weeks)
  • Appetite(4 weeks, 8 weeks)
  • Insulin Resistance(8 weeeks)
  • Anthropometric Measurement WC(4weeks, 8 weeks)
  • Anthropometric Measurement WHR(4 weeks, 8 weeks)
  • Anthropometric Measurement BMI(4 weeks, 8 weeks)
  • Peptide YY (PYY) Hormone(8 weeks)
  • Cholecystokinin (CKK) Hormone(8 weeks)
  • Fasting Blood Sugar(8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验